Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women.
about
Self-report measures of medication adherence behavior: recommendations on optimal useGastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS study.Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study in the Asia-Pacific Region (MUSIC OS-AP): Design of a multinational, prospective, observational study examining the impact of gastrointestinal events on osCompliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISACost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France.The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis.Impact of gastrointestinal events on patient-reported outcomes in Asia-Pacific women with osteoporosis: baseline results of the MUSIC OS-AP study.Adherence to oral bisphosphonates: 30 more minutes in dosing instructions matter.The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosis.Psychometric properties of the Osteoporosis-specific Morisky Medication Adherence Scale in postmenopausal women with osteoporosis newly treated with bisphosphonates.Validation of the Osteoporosis-Specific Morisky Medication Adherence Scale in long-term users of bisphosphonates.The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study.
P2860
Q26775742-AB3FB9C8-9EB1-4039-91E4-B45C47E63CBCQ30382163-D27DE294-BA8B-42F9-A4A7-ABEBED10F066Q30400736-CDCC41F3-8A50-4525-AFDF-AFA1156C5860Q30988951-E0B097E4-914B-49B5-A51B-D144B49BFE14Q33942472-1E928284-D56C-442F-BC1A-BEB64E93229BQ37998122-1EC992D7-1739-4488-8E4F-935BE216F849Q41039515-4746B59E-BF10-451F-96F2-0228AA6423D1Q41704724-5D4DB087-B1A2-43A3-9E2C-117054B12FE2Q44892769-2ACA90C2-AB12-48F4-B353-E55AD4D45D12Q45933539-823FE91F-252B-48A7-8F46-41A6F6DF7048Q46121990-0CE497DF-B770-4D6E-8F86-3E109872C4B8Q50129875-138C2583-54AD-41C3-BE22-0DCC9A9565F1
P2860
Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Validation of the adherence ev ...... porotic post-menopausal women.
@ast
Validation of the adherence ev ...... porotic post-menopausal women.
@en
type
label
Validation of the adherence ev ...... porotic post-menopausal women.
@ast
Validation of the adherence ev ...... porotic post-menopausal women.
@en
prefLabel
Validation of the adherence ev ...... porotic post-menopausal women.
@ast
Validation of the adherence ev ...... porotic post-menopausal women.
@en
P2093
P2860
P1476
Validation of the adherence ev ...... porotic post-menopausal women.
@en
P2093
A Regnault
A Roborel de Climens
A-F Gaudin
C Dias-Barbosa
P2860
P2888
P304
P356
10.1007/S00198-011-1555-8
P407
P577
2011-04-06T00:00:00Z